Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2009 June;51(2) > Panminerva Medica 2009 June;51(2):135-6

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

LETTERS TO THE EDITOR  


Panminerva Medica 2009 June;51(2):135-6

language: English

Pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C: role of steatosis and Body Mass Index

Testino G. 1, Sumberaz A. 2, Gentile R. 3, Ansaldi F. 1, Borro P. 2, Ravetti G. 3, Icardi G. 1

1 Department of Specialistic Medicine, S. Martino Hospital, Genoa, Italy
2 Unit of Histopathology, S. Martino Hospital, Genoa, Italy
3 Unit of Preventive Medicine, University of Genoa, Italy


PDF  


top of page

Publication History

Cite this article as

Corresponding author e-mail